Wall Street Journal: AstraZeneca and Pfizer Ask India for Emergency-Use Covid-19 Vaccine Authorizations
“The companies behind two of the most promising Covid-19 vaccine candidates, AstraZeneca PLC and Pfizer Inc., have asked India for emergency-use authorization to start using their vaccines in the South Asian nation, which has been one of the worst hit by the pandemic. Both Pfizer and Serum Institute of India — which is manufacturing AstraZeneca’s vaccine for developing countries — have applied for the authorization, which would allow their vaccines to circumvent a long trial and application process, said an official at the Drugs Controller General of India…” (Bellman, 12/7).

Additional coverage of the applications is available from Axios and Reuters.